137 related articles for article (PubMed ID: 22774570)
41. High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma.
Paradisi R; Vicenti R; Macciocca M; Seracchioli R; Rossi S; Fabbri R
Fertil Steril; 2016 Oct; 106(5):1176-1182. PubMed ID: 27430206
[TBL] [Abstract][Full Text] [Related]
42. Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.
He L; Shu X; Liu X; Ge Y; Li S; Lu X; Wang G
Mediators Inflamm; 2020; 2020():6243019. PubMed ID: 32774147
[TBL] [Abstract][Full Text] [Related]
43. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
Kamihira S; Atogami S; Sohda H; Momita S; Yamada Y; Tomonaga M
Cancer; 1994 Jun; 73(11):2753-8. PubMed ID: 8194016
[TBL] [Abstract][Full Text] [Related]
44. Basiliximab interferes with the detection of soluble IL-2 receptor by the Immulite Immunoassay system.
Warlé MC; Kwekkeboom J; Tilanus HW; Metselaar HJ
J Immunol Methods; 2003 Apr; 275(1-2):133-6. PubMed ID: 12667677
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system.
Berthier F; Lambert C; Genin C; Bienvenu J
Clin Chem Lab Med; 1999 May; 37(5):593-9. PubMed ID: 10418750
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of soluble interleukin-2 receptor.
Chrobák L
Acta Medica (Hradec Kralove); 1996; 39(1):3-6. PubMed ID: 9106384
[TBL] [Abstract][Full Text] [Related]
47. [The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma].
Akiyama K; Tsuji M; Kurokawa Y; Yokota K; Kojima K; Naruo S; Kanayana HO; Kagawa S
Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):473-8. PubMed ID: 9155114
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma.
Kita T; Watanabe S; Yano F; Hayashi K; Yamamoto M; Iwasaki Y; Kosuda S
Ann Nucl Med; 2007 Nov; 21(9):499-503. PubMed ID: 18030581
[TBL] [Abstract][Full Text] [Related]
49. Clinical significance of serum CD44 measurement in malignant lymphoma.
Fukuda Y
Kurume Med J; 2001; 48(1):65-9. PubMed ID: 11402623
[TBL] [Abstract][Full Text] [Related]
50. The soluble interleukin-2 receptor: biology, function, and clinical application.
Rubin LA; Nelson DL
Ann Intern Med; 1990 Oct; 113(8):619-27. PubMed ID: 2205142
[TBL] [Abstract][Full Text] [Related]
51. Soluble interleukin-2 receptor levels in patients with non-Hodgkin's lymphoma or with acute leukemia.
Chang CS; Lin SF; Liu HW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 May; 21(2):79-84. PubMed ID: 3264231
[TBL] [Abstract][Full Text] [Related]
52. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of serum soluble interleukin-2 receptor level in non-Hodgkin's lymphoma: a single center study in Japan.
Kono N; Kanda Y; Yamamoto R; Chizuka A; Suguro M; Hamaki T; Arai C; Matsuyama T; Takezako N; Miwa A; Togawa A
Leuk Lymphoma; 2000 Mar; 37(1-2):151-6. PubMed ID: 10721779
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.
Araki K; Harada K; Nakamoto K; Shiroma M; Miyakuni T
Clin Exp Immunol; 2000 Feb; 119(2):259-63. PubMed ID: 10632660
[TBL] [Abstract][Full Text] [Related]
55. Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease.
Handa T; Matsui S; Yoshifuji H; Kodama Y; Yamamoto H; Minamoto S; Waseda Y; Sato Y; Kubo K; Mimori T; Chiba T; Hirai T; Mishima M
Mod Rheumatol; 2018 Sep; 28(5):838-844. PubMed ID: 29251035
[TBL] [Abstract][Full Text] [Related]
56. Elevated soluble IL-2 receptor levels correlate with tumor bulk of follicular lymphomas with intestinal involvement.
Iwamuro M; Shinagawa K; Okada H; Takata K; Yoshino T; Yamamoto K
Clin Biochem; 2014 Feb; 47(3):191-5. PubMed ID: 24362271
[TBL] [Abstract][Full Text] [Related]
57. Serum soluble interleukin-2 receptor in eosinophilia.
Kaito K; Otsubo H; Ogasawara Y; Kimura H; Kurihara E; Koike M; Aiso M; Kobayashi M
Acta Haematol; 2003; 109(1):23-8. PubMed ID: 12486319
[TBL] [Abstract][Full Text] [Related]
58. Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease.
Karim AF; Eurelings LEM; Bansie RD; van Hagen PM; van Laar JAM; Dik WA
Mediators Inflamm; 2018; 2018():6103064. PubMed ID: 29686532
[TBL] [Abstract][Full Text] [Related]
59. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival.
Wagner DK; Kiwanuka J; Edwards BK; Rubin LA; Nelson DL; Magrath IT
J Clin Oncol; 1987 Aug; 5(8):1262-74. PubMed ID: 3114436
[TBL] [Abstract][Full Text] [Related]
60. Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma.
Uziel Y; Krafchik BR; Feldman B; Silverman ED; Rubin LA; Laxer RM
Arthritis Rheum; 1994 Jun; 37(6):898-901. PubMed ID: 8003062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
